Literature DB >> 9498819

Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma.

A Giuffrida1, D Piomelli.   

Abstract

Anandamide and allied fatty acylethanolamides (AEs) may act as signalling molecules in brain and peripheral tissues. In the present study, we describe an electron-impact gas chromatography/mass spectrometry (GC/MS) method based on isotope dilution, which may be used for the identification and quantification of anandamide and other AEs in biological matrices. The calibration curves for standard AEs were linear over the range 0-1000 pmol (r2 = 0.99) with a coefficient of variation of 4% at 2.5 pmol. Detection and quantification limits were in the high fmol to low pmol range for all AEs. Using this method we measured nanomolar concentrations of three endogenous AEs in deproteinated rat blood plasma (anandamide: 5.2 pmol/ml; palmitylethanolamide: 16.7 pmol/ml; oleylethanolamide: 8.1 pmol/ml). These results are consistent with a regulatory role of anandamide and other AEs in peripheral tissues.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498819     DOI: 10.1016/s0014-5793(98)00046-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  20 in total

Review 1.  Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Authors:  Matthew W Buczynski; Loren H Parsons
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  The fatty acid amide hydrolase inhibitor URB 597: interactions with anandamide in rhesus monkeys.

Authors:  Jennifer L Stewart; Lance R McMahon
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

3.  In vivo monitoring of rat brain endocannabinoids using solid-phase microextraction.

Authors:  Momna Aslam; Carlos Feleder; Ryan J Newsom; Serge Campeau; Florin Marcel Musteata
Journal:  Bioanalysis       Date:  2019-09-05       Impact factor: 2.681

4.  Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice.

Authors:  R Capasso; A A Izzo; F Fezza; A Pinto; F Capasso; N Mascolo; V Di Marzo
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

5.  Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system.

Authors:  A Straiker; N Stella; D Piomelli; K Mackie; H J Karten; G Maguire
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

6.  Mammalian cells stably overexpressing N-acylphosphatidylethanolamine-hydrolysing phospholipase D exhibit significantly decreased levels of N-acylphosphatidylethanolamines.

Authors:  Yasuo Okamoto; Jun Morishita; Jun Wang; Patricia C Schmid; Randy J Krebsbach; Harald H O Schmid; Natsuo Ueda
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

Review 7.  The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations.

Authors:  Stefania Petrosino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2016-09-29       Impact factor: 8.739

Review 8.  Lipidomic analysis of endocannabinoid metabolism in biological samples.

Authors:  Giuseppe Astarita; Daniele Piomelli
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-01-14       Impact factor: 3.205

9.  Anandamide extends platelets survival through CB(1)-dependent Akt signaling.

Authors:  Maria Valeria Catani; Valeria Gasperi; Daniela Evangelista; Alessandro Finazzi Agrò; Luciana Avigliano; Mauro Maccarrone
Journal:  Cell Mol Life Sci       Date:  2009-11-20       Impact factor: 9.261

10.  Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.

Authors:  Lance R McMahon
Journal:  Psychopharmacology (Berl)       Date:  2008-07-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.